NOW LIVE: Eyewitness News

Vivus Inc.

Anti Obesity Drug

FDA Panel Overwhelmingly Backs Approval Of Anti-Obesity Pill

A panel of advisers to the Food and Drug Administration overwhelmingly backed approval for a highly anticipated anti-obesity pill from Vivus Inc., a drug which the FDA previously rejected due to safety concerns.

02/22/2012

Follow

Get every new post delivered to your Inbox.

Join 34,965 other followers